Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Leport

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
Annales De La Societe Belge De Medecine Tropicale|January 1, 1984
Acquired immunodeficiency syndrome (AIDS) in AfricansC Katlama, C Leport, S Matheron, et al.
Archives of Internal Medicine|March 8, 1993
Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditisP Brouqui, H T Dupont, M Drancourt, et al.
AIDS Care|October 18, 2011
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerabilityM Préau, C Protopopescu, F Raffi, et al.
Digestive Diseases and Sciences|June 1, 1988
Cytomegalovirus colitis in patients with acquired immunodeficiency syndromeE Rene, C Marche, T Chevalier, et al.
AIDS Care|June 30, 2004
Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatmentM Préau, C Leport, D Salmon-Ceron, et al.
Revue D'Epidemiologie Et De Sante Publique|December 11, 2017
Need for integrative thinking to fight against emerging infectious diseases. Proceedings of the 5th seminar on emerging infectious diseases, March 22, 2016 - current trends and proposalsC Burdet, J-F Guégan, X Duval, et al.
HIV Medicine|April 28, 2007
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsV Le Moing, R Thiébaut, G Chêne, et al.
Annales De Medecine Interne|January 1, 1996
[Risk factors of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention]C Leport, P Ambroise-Thomas, C Bazin, et al.
Diabetes & Metabolism|March 14, 2019
Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patientsJ-P Bastard, C Couffignal, S Fellahi, et al.
Presse Medicale (Paris, France : 1983)|March 30, 1996
[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February]C Leport, P Ambroise-Thomas, C Bazin, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
Annales De La Societe Belge De Medecine Tropicale|January 1, 1984
Acquired immunodeficiency syndrome (AIDS) in AfricansC Katlama, C Leport, S Matheron, et al.
Archives of Internal Medicine|March 8, 1993
Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditisP Brouqui, H T Dupont, M Drancourt, et al.
AIDS Care|October 18, 2011
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerabilityM Préau, C Protopopescu, F Raffi, et al.
Digestive Diseases and Sciences|June 1, 1988
Cytomegalovirus colitis in patients with acquired immunodeficiency syndromeE Rene, C Marche, T Chevalier, et al.
AIDS Care|June 30, 2004
Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatmentM Préau, C Leport, D Salmon-Ceron, et al.
Revue D'Epidemiologie Et De Sante Publique|December 11, 2017
Need for integrative thinking to fight against emerging infectious diseases. Proceedings of the 5th seminar on emerging infectious diseases, March 22, 2016 - current trends and proposalsC Burdet, J-F Guégan, X Duval, et al.
HIV Medicine|April 28, 2007
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsV Le Moing, R Thiébaut, G Chêne, et al.
Annales De Medecine Interne|January 1, 1996
[Risk factors of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention]C Leport, P Ambroise-Thomas, C Bazin, et al.
Diabetes & Metabolism|March 14, 2019
Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patientsJ-P Bastard, C Couffignal, S Fellahi, et al.
Presse Medicale (Paris, France : 1983)|March 30, 1996
[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February]C Leport, P Ambroise-Thomas, C Bazin, et al.
Pageof 24